A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
C01 CARDIAC THERAPY
|
C02 ANTIHYPERTENSIVES
|
C03 DIURETICS
|
C04 PERIPHERAL VASODILATORS
|
C05 VASOPROTECTIVES
|
C07 BETA BLOCKING AGENTS
|
C08 CALCIUM CHANNEL BLOCKERS
|
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
|
C10 LIPID MODIFYING AGENTS
|
C10A LIPID MODIFYING AGENTS, PLAIN
|
C10AA HMG CoA reductase inhibitors [DG:DG01660]
|
C10AB Fibrates
|
C10AC Bile acid sequestrants
|
C10AD Nicotinic acid and derivatives
|
C10AX Other lipid modifying agents
|
C10AX01 Dextrothyroxine
|
C10AX02 Probucol
|
D00476 Probucol (JP18/USP/INN) <JP>
|
C10AX03 Tiadenol
|
C10AX05 Meglutol
|
C10AX06 Omega-3-triglycerides incl. other esters and acids
|
C10AX07 Magnesium pyridoxal 5-phosphate glutamate
|
C10AX08 Policosanol
|
C10AX09 Ezetimibe
|
C10AX10 Alipogene tiparvovec
|
C10AX11 Mipomersen
|
C10AX12 Lomitapide [DG:DG00362]
|
C10AX13 Evolocumab
|
C10AX14 Alirocumab
|
C10AX15 Bempedoic acid
|
C10AX16 Inclisiran [DG:DG03216]
|
C10AX17 Evinacumab
|
C10AX18 Volanesorsen [DG:DG03070]
|
C10B LIPID MODIFYING AGENTS, COMBINATIONS
|
|
D DERMATOLOGICALS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|